Literature DB >> 23516676

Monitoring hepatitis C infection in the liver allograft.

Bertus Eksteen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23516676      PMCID： PMC3732149          DOI： 10.1155/2013/297218

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN： 0835-7900            Impact factor:   3.522


× No keyword cloud information.
  9 in total

1.  Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.

Authors:  Marie-Luise Berres; Christian Trautwein; Maximilian Schmeding; Dennis Eurich; Frank Tacke; Marcus Bahra; Peter Neuhaus; Ulf P Neumann; Hermann E Wasmuth
Journal:  Hepatology       Date:  2011-01-10       Impact factor: 17.425

2.  Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006).

Authors:  Didier Samuel; Xavier Forns; Marina Berenguer; Christian Trautwein; Andrew Burroughs; Mario Rizzetto; Christian Trepo
Journal:  J Hepatol       Date:  2006-05-15       Impact factor: 25.083

3.  Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive index.

Authors:  Salvador Benlloch; Marina Berenguer; Martín Prieto; José Miguel Rayón; Victoria Aguilera; Joaquín Berenguer
Journal:  Liver Transpl       Date:  2005-04       Impact factor: 5.799

4.  Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation.

Authors:  Jose A Carrión; Miquel Navasa; Jaume Bosch; Miquel Bruguera; Rosa Gilabert; Xavier Forns
Journal:  Liver Transpl       Date:  2006-12       Impact factor: 5.799

5.  Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation.

Authors:  José A Carrión; Guillermo Fernández-Varo; Miquel Bruguera; Juan-Carlos García-Pagán; Juan-Carlos García-Valdecasas; Sofía Pérez-Del-Pulgar; Xavier Forns; Wladimiro Jiménez; Miquel Navasa
Journal:  Gastroenterology       Date:  2009-09-26       Impact factor: 22.682

6.  Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation.

Authors:  Alejandro Blasco; Xavier Forns; José A Carrión; Juan Carlos García-Pagán; Rosa Gilabert; Antoni Rimola; Rosa Miquel; Miquel Bruguera; Juan-Carlos García-Valdecasas; Jaime Bosch; Miquel Navasa
Journal:  Hepatology       Date:  2006-03       Impact factor: 17.425

7.  Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.

Authors:  Susan C Abraham; John J Poterucha; Charles B Rosen; Anthony J Demetris; Alyssa M Krasinskas
Journal:  Am J Surg Pathol       Date:  2008-07       Impact factor: 6.394

Review 8.  Progression of liver fibrosis in post-transplant hepatitis C: mechanisms, assessment and treatment.

Authors:  Marina Berenguer; Detlef Schuppan
Journal:  J Hepatol       Date:  2012-12-20       Impact factor: 25.083

9.  Serum aspartate aminotransferase levels and previous histopathological findings enable reduction of protocol liver biopsies after liver transplantation for hepatitis C.

Authors:  Tomohiro Tanaka; George Therapondos; Nazia Selzner; Eberhard L Renner; Leslie B Lilly
Journal:  Can J Gastroenterol       Date:  2013-03       Impact factor: 3.522
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.